Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system

Introduction The generation of human induced pluripotent stem cells (hiPSCs) with homogeneous and stable quality at an affordable cost is key to industrialize hiPSC-based cell therapies and drug development; however, conventional manual production is labor-intensive and difficult to standardize. Automated closed-system approaches can improve reproducibility, reduce contamination risk, and enable scale-out manufacturing, yet concerns remain regarding the quality of hiPSCs produced using this approach specialized in hiPSC generation from peripheral blood cells. Methods Here we developed a prototype semi-automated hiPSC production system to generate polyclonal hiPSC lines from peripheral blood cells. The semi-automated device consists of a spiral microfluidic module for leukocyte separation, followed by modules for leukocyte expansion culture and the transduction of a Sendai virus (SeV) vector carrying reprogramming factors. Subsequently, the transduced leukocytes were manually cultured and expanded to generate polyclonal hiPSC lines. Results The generated polyclonal hiPSC populations maintained a normal karyotype and carried minimal residual SeV vector. Importantly, they exhibited self-renewing capacity and pluripotency comparable to those of established clonal hiPSC lines. Furthermore, when subjected to directed differentiation towards cartilage and kidney organoids, the polyclonal hiPSC lines efficiently differentiated into these lineages. Conclusions The semi-automated system enabled the generation of high-quality polyclonal hiPSC lines, which will hold promise for future applications in cell therapy and drug development.

Authors

Institutions

Publication Details

Journal
Regenerative Therapy
Published
2026-11-14
DOI
https://doi.org/10.1016/j.reth.2026.101201
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system

Takeshi Takarada, Keiichiro Kamura, Suzu Oe, Atsuhiro Taguchi et al.
Regenerative Therapy
Pluripotent Stem Cells Research
article

Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system

Takeshi Takarada, Keiichiro Kamura, Suzu Oe, Atsuhiro Taguchi, Yohei Hayashi, Yuki Fujisawa, Tomoka Takao, Tsutomu Miki, Momoko Kano, Yan Lu, Yusuke Owaki
article en

Abstract

Introduction The generation of human induced pluripotent stem cells (hiPSCs) with homogeneous and stable quality at an affordable cost is key to industrialize hiPSC-based cell therapies and drug development; however, conventional manual production is labor-intensive and difficult to standardize. Automated closed-system approaches can improve reproducibility, reduce contamination risk, and enable scale-out manufacturing, yet concerns remain regarding the quality of hiPSCs produced using this approach specialized in hiPSC generation from peripheral blood cells. Methods Here we developed a prototype semi-automated hiPSC production system to generate polyclonal hiPSC lines from peripheral blood cells. The semi-automated device consists of a spiral microfluidic module for leukocyte separation, followed by modules for leukocyte expansion culture and the transduction of a Sendai virus (SeV) vector carrying reprogramming factors. Subsequently, the transduced leukocytes were manually cultured and expanded to generate polyclonal hiPSC lines. Results The generated polyclonal hiPSC populations maintained a normal karyotype and carried minimal residual SeV vector. Importantly, they exhibited self-renewing capacity and pluripotency comparable to those of established clonal hiPSC lines. Furthermore, when subjected to directed differentiation towards cartilage and kidney organoids, the polyclonal hiPSC lines efficiently differentiated into these lineages. Conclusions The semi-automated system enabled the generation of high-quality polyclonal hiPSC lines, which will hold promise for future applications in cell therapy and drug development.

Regenerative TherapyVol. 33
Canon (Japan) (JP), Chiba University (JP), Okayama University (JP), Institute for Advanced Academic Research, Chiba University (JP)
Pluripotent Stem Cells Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon